Results
eNauka >
Results >
A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment
Title: | A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment | Authors: | Mistry, Pramod K; Lukina, Elena; Ben, Dridi Marie-Francoise; Amato, Dominick J; Baris, Hagit; Dasouki, Majed; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory M; | Issue Date: | 2013 | Publication: | MOLECULAR GENETICS AND METABOLISM | ISSN: | 1096-7192 Molecular Genetics and Metabolism Search Idenfier | Type: | Conference Paper | Collation: | vol. 108 br. 2 str. S66-S67 | DOI: | 10.1016/j.ymgme.2012.11.171 | WoS-ID: | 000314670500159 | URI: | https://enauka.gov.rs/handle/123456789/825819 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.